2008
DOI: 10.1124/mol.108.046847
|View full text |Cite
|
Sign up to set email alerts
|

Protection against Hydrogen Peroxide-Mediated Cytotoxicity in Friedreich's Ataxia Fibroblasts Using Novel Iron Chelators of the 2-Pyridylcarboxaldehyde Isonicotinoyl Hydrazone Class

Abstract: Iron-loading diseases remain an important problem because of the toxicity of iron-catalyzed redox reactions. Iron loading occurs in the mitochondria of Friedreich's ataxia (FA) patients and may play a role in its pathogenesis. This suggests that iron chelation therapy could be useful. We developed previously the lipophilic iron chelators known as the 2-pyridylcarboxaldehyde isonicotinoyl hydrazone (PCIH) ligands and identified 2-pyridylcarboxaldehyde 2-thiophenecarboxyl hydrazone (PCTH) as the most promising a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
27
0

Year Published

2009
2009
2018
2018

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 38 publications
(27 citation statements)
references
References 39 publications
0
27
0
Order By: Relevance
“…Previous studies have shown that the prototype iron chelator DFO captures the labile iron pool, resulting in decreased cell death arising from several types of oxidant challenge (Ollinger and Brunk, 1995;Winterbourn, 1995). However, DFO, suffers from several problems that are due, in part, to its hydrophilicity (Kalinowski and Richardson, 2005), leading to poor absorption from the gut and poor penetration of cell membranes that prevents access to intracellular Fe 2ϩ pools (Lim et al, 2008). The protective effect of M30 and HLA20 on ␤-cells was accompanied by decreased formation of intracellular ROS after acute H 2 O 2 exposure and an enhanced activity of the antioxidant detoxifying enzyme catalase.…”
Section: Discussionmentioning
confidence: 99%
“…Previous studies have shown that the prototype iron chelator DFO captures the labile iron pool, resulting in decreased cell death arising from several types of oxidant challenge (Ollinger and Brunk, 1995;Winterbourn, 1995). However, DFO, suffers from several problems that are due, in part, to its hydrophilicity (Kalinowski and Richardson, 2005), leading to poor absorption from the gut and poor penetration of cell membranes that prevents access to intracellular Fe 2ϩ pools (Lim et al, 2008). The protective effect of M30 and HLA20 on ␤-cells was accompanied by decreased formation of intracellular ROS after acute H 2 O 2 exposure and an enhanced activity of the antioxidant detoxifying enzyme catalase.…”
Section: Discussionmentioning
confidence: 99%
“…The first aroylhydrazones were derived from pyridoxal isonicotinoyl hydrazone, highly effective and lipophilic molecules that prevent iron uptake while mobilizing intracellular iron (268). Subsequently, new iron chelators known as the 2-pyridylcarboxaldehyde isonicotinoyl hydrazone analogs were developed.…”
Section: Therapeutic Optionsmentioning
confidence: 99%
“…Subsequently, new iron chelators known as the 2-pyridylcarboxaldehyde isonicotinoyl hydrazone analogs were developed. Initial studies revealed that isonicotinoyl hydrazone was not a selective iron chelator and instead, formed a more stable complex with copper (268,344). This led to subsequent derivatives, of which 2-pyridylcarboxaldehyde 2-thiophenecarboxyl hydrazone (PCTH) was the most effective (465).…”
Section: Therapeutic Optionsmentioning
confidence: 99%
See 1 more Smart Citation
“…Idebenone inhibits ROS accumulation and prevents H 2 O 2 -induced cytotoxicity (Lim et al 2008). On the other hand, our direct monitoring of the ROS levels revealed that MA-5 had no effect on the cellular ROS levels under basal and H 2 O 2 -treated conditions (Fig.…”
Section: Ma-5 Mediates a Novel Mechanism For Sustentationmentioning
confidence: 99%